These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 150082)

  • 21. The crossmatch in renal transplantation. Evaluation of flow cytometry as a replacement for standard cytotoxicity.
    Scornik JC; Brunson ME; Schaub B; Howard RJ; Pfaff WW
    Transplantation; 1994 Feb; 57(4):621-5. PubMed ID: 8116050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of histocompatibility testing versus immunoreactive predisposition on kidney transplant survival.
    Kyriakides GK; Severyn W; Fuller L; Esquenazi V; Flaa C; Olson L; Miller J
    Surgery; 1982 Aug; 92(2):354-61. PubMed ID: 6213054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-transplant monitoring of renal allograft recipients for T, B and null lymphocyte subpopulations.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1977 Apr; 28(1):123-9. PubMed ID: 140776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed lymphocyte culture responses. Lack of correlation with cadaveric renal allograft survival and blood transfusions.
    Jeffery JR; Cheung K; Masniuk J; Taylor D
    Transplantation; 1984 Jul; 38(1):42-5. PubMed ID: 6234685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The correlation of cadaver renal donor response in the mixed lymphocyte reaction with recipient renal allograft survival.
    Tait BD; d'Apice AJ; Cove LY
    Transplant Proc; 1979 Jun; 11(2):1248-9. PubMed ID: 157567
    [No Abstract]   [Full Text] [Related]  

  • 26. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation.
    Comoli P; Ginevri F; Maccario R; Avanzini MA; Marconi M; Groff A; Cometa A; Cioni M; Porretti L; Barberi W; Frassoni F; Locatelli F
    Nephrol Dial Transplant; 2008 Apr; 23(4):1196-202. PubMed ID: 18029377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blastogenic suppression and alloantibody activity of sera from renal allograft recipients.
    Johnson AH; Rossen RD; Hersh EM; Farrow SS; Butler WT; Suki WN
    J Clin Invest; 1974 Jan; 53(1):270-8. PubMed ID: 4271573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evidence of a specific defect in effector cell formation following kidney and liver allotransplants in humans].
    Wonigkeit K; Pichlmayr R
    Chir Forum Exp Klin Forsch; 1977 Apr; ():269-73. PubMed ID: 156112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between mixed lymphocyte culture in compatibility and cadaver kidney graft rejection.
    Thomsen M; Dickmeiss E
    Scand J Urol Nephrol Suppl; 1977; (42):40-3. PubMed ID: 150639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crossmatching with B and T cells and flow cytometry.
    Iwaki Y; Lau M; Cook DJ; Takemoto S; Terasaki PI
    Clin Transpl; 1986; ():277-84. PubMed ID: 3154417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MLR inhibitory activity of pretransplant anti-donor B cell antibodies, and kidney graft survival.
    Lenhard V; Diehm H; Rettwitz W; Dreikorn K
    Proc Eur Dial Transplant Assoc; 1981; 18():433-8. PubMed ID: 6460245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion.
    Quigley RL; Wood KJ; Morris PJ
    Immunology; 1988 Mar; 63(3):373-81. PubMed ID: 2965097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of mixed lymphocyte culture (MLC) in renal transplants from living donors].
    Zanuso C; Pontiero P; Ancona G; Galvani E; Confortini P
    Minerva Chir; 1980 May; 35(10):791-2. PubMed ID: 6450337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated mixed lymphocyte culture test potentially useful for cadaver organ transplantation.
    McCombs CC; Michalski JP
    J Clin Lab Immunol; 1982 Sep; 8(3):207-10. PubMed ID: 6215493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
    Nunez G; McPhaul J; Stastny P
    Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
    Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
    Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
    Creemers P; Brink J; Kahn D
    Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts.
    Genden EM; Mackinnon SE; Yu S; Hunter DA; Flye MW
    Laryngoscope; 2001 Mar; 111(3):439-47. PubMed ID: 11224773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK
    Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.